Strategene Gives Up Fight With Third Wave
After years of battling over genetic testing patents, molecular diagnostics company Stratagene Corp. has agreed to fork over $10.75 million to rival Third Wave Technologies Inc. as part of an out-of-court...To view the full article, register now.
Already a subscriber? Click here to view full article